Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Revenue and gross margin remained stable in H1 2026, with adjusted EBITDA growth and strong Life Sciences performance. The order book supports confidence in meeting FY 2026 guidance, while share buybacks and strategic investments continue.Original document: EKF Diagnostics Holdings plc [EKF] Interi…
Revenue and gross margin remained stable in H1 2026, with Life Sciences driving growth and Point-of-Care set for recovery in H2. Adjusted EBITDA rose 2.4%, and the company remains confident in meeting FY 2026 guidance, supported by a strong order book and ongoing strategic investments.Original docu…